ABBV: AbbVie Inc
ABBV exchange rate has changed by 0.26% for today. During the day, the instrument was traded at a low of 206.52 and at a high of 209.66.
Follow AbbVie Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ABBV News
- AbbVie (ABBV) Gains As Market Dips: What You Should Know
- IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?
- AbbVie: Strong 2026 Outlook, Expect Dividend Increases (NYSE:ABBV)
- Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?
- J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026
- Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios (NYSE:JNJ)
- Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
- LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026?
- Protagonist Partners With JNJ To Compete With AbbVie's Skyrizi (PTGX)
- How Apogee, Up Almost 20%, Plans To Take On Rival Regeneron's Eczema Drug
- SCHD ETF Slips Ahead of Portfolio Reshuffle — UNH, QCOM In; HAL, VLO Out - TipRanks.com
- Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why
- AbbVie (ABBV) Declines More Than Market: Some Information for Investors
- J&J Expands New Drug Portfolio With Icotyde's FDA Approval
- ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
- Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Johnson & Johnson (NYSE:JNJ), Protagonist Therapeutics (NASDAQ:PTGX)
- Best Dividend Kings: March 2026
- AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?
- Here's Why AbbVie (ABBV) is a Strong Value Stock
- Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
- Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)
- AbbVie (ABBV) Dips More Than Broader Market: What You Should Know
- Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation
- IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
Frequently Asked Questions
What is ABBV stock price today?
AbbVie Inc stock is priced at 208.98 today. It trades within 206.52 - 209.66, yesterday's close was 208.43, and trading volume reached 8459. The live price chart of ABBV shows these updates.
Does AbbVie Inc stock pay dividends?
AbbVie Inc is currently valued at 208.98. Dividend policy depends on the company, while investors also watch 8.35% and USD. View the chart live to track ABBV movements.
How to buy ABBV stock?
You can buy AbbVie Inc shares at the current price of 208.98. Orders are usually placed near 208.98 or 209.28, while 8459 and 0.96% show market activity. Follow ABBV updates on the live chart today.
How to invest into ABBV stock?
Investing in AbbVie Inc involves considering the yearly range 176.57 - 244.81 and current price 208.98. Many compare -4.37% and -3.72% before placing orders at 208.98 or 209.28. Explore the ABBV price chart live with daily changes.
What are AbbVie Inc stock highest prices?
The highest price of AbbVie Inc in the past year was 244.81. Within 176.57 - 244.81, the stock fluctuated notably, and comparing with 208.43 helps spot resistance levels. Track AbbVie Inc performance using the live chart.
What are AbbVie Inc stock lowest prices?
The lowest price of AbbVie Inc (ABBV) over the year was 176.57. Comparing it with the current 208.98 and 176.57 - 244.81 shows potential long-term entry points. Watch ABBV moves on the chart live for more details.
When did ABBV stock split?
AbbVie Inc has gone through stock splits historically. These changes are visible in , 208.43, and 8.35% after corporate actions.
- Previous Close
- 208.43
- Open
- 207.00
- Bid
- 208.98
- Ask
- 209.28
- Low
- 206.52
- High
- 209.66
- Volume
- 8.459 K
- Daily Change
- 0.26%
- Month Change
- -4.37%
- 6 Months Change
- -3.72%
- Year Change
- 8.35%
- Act
- 26.7
- Fcst
- 3.3
- Prev
- 18.1
- Act
- -5.1
- Fcst
- 11.5
- Prev
- 0.8
- Act
- 207 K
- Fcst
- 212 K
- Prev
- 218 K
- Act
- 1.818 M
- Fcst
- 1.832 M
- Prev
- 1.787 M
- Act
- -0.5%
- Fcst
- -0.1%
- Prev
- 0.7%
- Act
- 0.7%
- Fcst
- 2.1%
- Prev
- 1.4%